EBP - EBP cholestenol delta-isomerase Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 515569
EBP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001034500.1 | NP_001029672.1 | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0660 | Eicosapentaenoic Acid | Activator | 98.07% | Yes |
| HY-10466 | Daclatasvir | Inhibitor | 99.57% | Unkown |
| HY-10465 | Daclatasvir dihydrochloride | Inhibitor | 99.82% | Unkown |
| HY-10237 | Boceprevir | Inhibitor | 98.52% | Unkown |
| HY-W011269 | Eicosapentaenoic Acid sodium | Activator | 95.78% | Yes |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-132607A | MTL-CEBPA sodium | 91.62% | Phase 2 | |
| HY-132607 | MTL-CEBPA | 95.52% | Phase 2 | |
| HY-13766 | Timcodar | Inhibitor | 99.66% | Phase 2 |
| HY-132168 | RMC-5552 | Inhibitor | 99.94% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(81)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-110188 | BiP inducer X | Inhibitor | 99.62% | Unkown |
| HY-N4103 | Fucosterol | Inhibitor | 98.27% | Unkown |
| HY-12461 | WS6 | 99.09% | Unkown | |
| HY-164561 | TASIN-30 | 99.96% | Unkown | |
| HY-116572A | TASIN-1 | 98.09% | Unkown | |
| HY-N0704 | Agrimol B | 99.75% | Unkown | |
| HY-162351 | EBP-IN-1 | Inhibitor | 99.77% | Unkown |
| HY-N1677 | 2,6-Dimethoxy-1,4-benzoquinone | 98.72% | Unkown | |
| HY-N6954 | Garcinone C | 99.51% | Unkown | |
| HY-N0777 | Isorhamnetin-3-O-glucoside | 99.96% | Unkown | |
| HY-12462 | WS3 | 98.70% | Unkown | |
| HY-N0656A | (+)-Usnic acid | 99.64% | Unkown | |
| HY-N4177 | Rubrofusarin gentiobioside | Inhibitor | 99.04% | Unkown |
| HY-114519 | Helenalin acetate | Inhibitor | 99.55% | Unkown |
| HY-134334 | C/EBPα inducer 1 | 99.82% | Unkown | |
| HY-N14035 | Garcinia cambogia extract | Activator | / | Unkown |
| HY-134333 | ICCB280 | Activator | 98.14% | Unkown |
| HY-115590 | JP-11646 | 98.74% | Unkown | |
| HY-128671 | 6-Thioinosine | 99.31% | Unkown | |
| HY-143510 | RMC-4627 | 99.20% | Unkown | |
| HY-P5275 | Tripeptide-41 | 99.30% | Unkown | |
| HY-W348485 | WRX606 | Inhibitor | 95.65% | Unkown |
| HY-130723A | AMPK activator 2 hydrochloride | Activator | 99.68% | Unkown |
| HY-134903 | (32-Carbonyl)-RMC-5552 | Inhibitor | 95.41% | Unkown |
| HY-N11709 | Theasaponin E1 | 98.68% | Unkown | |
| HY-P10323A | T7 Peptide TFA | 98.20% | Unkown | |
| HY-114267 | Cbz-B3A | Inhibitor | 98.63% | Unkown |
| HY-176761 | NSC647889 | 99.28% | Unkown | |
| HY-N15574 | Saringosterol | ≥90.0% | Unkown | |
| HY-RS04277 | EIF4EBP1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W412264 | Pim-1/2 kinase inhibitor 1 | Inhibitor | 99.78% | Unkown |
| HY-124348 | DM-PIT-1 | Inhibitor | 99.9% | Unkown |
| HY-172609 | SL-176 | 99.91% | Unkown | |
| HY-N3027 | Soyasaponin Aa | Inhibitor | 99.88% | Unkown |
| HY-N7661 | 4β-Hydroxywithanolide E | Inhibitor | 98% | Unkown |
| HY-P11642A | Sialorphin TFA | / | Unkown | |
| HY-111370 | mTOR inhibitor-2 | Inhibitor | / | Unkown |
| HY-10237S | Boceprevir-d9 | Inhibitor | / | Unkown |
| HY-10062 | AZD3409 | Inhibitor | / | Unkown |
| HY-10466BS | Daclatasvir-d6 hydrochloride | / | Unkown | |
| HY-10466S | Daclatasvir-d6 | Inhibitor | 99.64% | Unkown |
| HY-10466S2 | Daclatasvir-d16 | Inhibitor | / | Unkown |
| HY-115869 | RMC-4529 | Inhibitor | / | Unkown |
| HY-119831 | Rohitukine | / | Unkown | |
| HY-121033 | BS148 | / | Unkown | |
| HY-122670 | VS-II-173 | / | Unkown | |
| HY-126956 | Porphyra 334 | / | Unkown | |
| HY-130723 | AMPK activator 2 | Activator | / | Unkown |
| HY-149292 | SR-4133 | Inhibitor | / | Unkown |
| HY-157482 | EBP-59 | Inhibitor | / | Unkown |
| HY-157828 | DSP-0390 | Inhibitor | / | Unkown |
| HY-169751 | Dihydro-N-caffeoyltyramine | Inhibitor | / | Unkown |
| HY-176948 | M-1111 | Inhibitor | / | Unkown |
| HY-181650 | T133 | / | Unkown | |
| HY-181925 | FD2024 | / | Unkown | |
| HY-182957 | MNK/PIM-IN-2 | / | Unkown | |
| HY-B0660S1 | Eicosapentaenoic acid 1,2,3,4,5-13C5 | Activator | / | Unkown |
| HY-B0660S2 | Eicosapentaenoic acid-d10 | / | Unkown | |
| HY-N11507 | Tibesaikosaponin V | Inhibitor | / | Unkown |
| HY-N15121 | 4-O-Methyl-ascochlorin | / | Unkown | |
| HY-N3027R | Soyasaponin Aa (Standard) | Inhibitor | / | Unkown |
| HY-N4103R | Fucosterol (Standard) | Inhibitor | / | Unkown |
| HY-P10323 | T7 Peptide | / | Unkown | |
| HY-P11642 | Sialorphin | / | Unkown | |
| HY-P6183 | LXJ-02 | Inducer | / | Unkown |
| HY-RS04130 | EBP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04278 | EIF4EBP2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04279 | EIF4EBP3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05464 | GLB1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12834 | SH3D19 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-10466S1 | Daclatasvir-13C2,d6 | Inhibitor | / | Unkown |
| HY-116572 | TASIN-1 hydrochloride | / | Unkown | |
| HY-B0660A | Eicosapentaenoic acid metformin | Activator | / | Unkown |
| HY-N10612 | Petasin | / | Unkown | |
| HY-N1677R | 2,6-Dimethoxy-1,4-benzoquinone (Standard) | / | Unkown | |
| HY-RS18892 | Ebp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20227 | Eif4ebp1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20664 | Eif4ebp2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25383 | Ebp Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26734 | Eif4ebp1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27175 | Eif4ebp2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |